Bengaluru, India—Three more Sami-Sabinsa Group Manufacturing units have been audited by the United States Pharmacopeia (USP) and received GMP compliance certificates for the Kunigal unit and the Dobaspet unit, both in Bengaluru, and the Hyderabad unit in Telangana state, India, according to a press release. The sites are certified Halal and OK Kosher. The Kunigal and Hyderabad units are NSF-GMP certified.
The USP GMP certificate, the press release says, recognizes that the facilities and their quality systems meet the requirements set for in 21 CFR Part 117 Current Good Manufacturing Practice, Hazard Analysis and Risk-Based Preventive Controls for Human Food, and USP-NF general chapter <2750> Manufacturing Practices for Dietary Supplements for Dietary Ingredient manufacturing.
The units produce several of Sabinsa’s ingredients, according to the release, ranging from standardized botanical extracts to nutritional and specialty fine chemicals.
Dr. Muhammad Majeed, founder of Sabinsa, said in the release: “We’re pleased to have this assurance from USP reaffirm that our manufacturing facilities comply with U.S. cGMP requirements. While we welcome and encourage customers to tour our facilities, USP audits can be reassuring for those not able to do so in person.”